Juby Anne Jacob-Nara
11PUBLICATIONS
49CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Aug 06, 2025
Impact of asthma age of onset or duration on efficacy of dupilumab in moderate-to-severe type 2 asthma.William W Busse, Monica Kraft, Christian Domingo
|Feb 05, 2025
Dupilumab is efficacious for eosinophilic esophagitis irrespective of prior swallowed budesonide or fluticasone, or prior treatments used alongside swallowed topical corticosteroids: results from the phase 3, randomized, placebo-controlled, LIBERTY EoE TREET trial.Albert J Bredenoord, Evan S Dellon, Christoph Schlag
|Dec 02, 2024
Dupilumab improves sense of smell and clinical outcomes in patients with severe chronic rhinosinusitis with nasal polyps with anosmia.Andrew P Lane, Joaquim Mullol, Claire Hopkins
|Jan 22, 2024
Dupilumab Reduces Asthma Disease Burden and Recurrent SCS Use in Patients with CRSwNP and Coexisting Asthma.Mark Gurnell, Amr Radwan, Claus Bachert
|Dec 29, 2023
Impact of Dupilumab on Sinonasal Symptoms and Outcomes in Severe Chronic Rhinosinusitis With Nasal Polyps.Claire Hopkins, Joaquim Mullol, Asif H Khan
|Jul 11, 2023
Dupilumab sustains efficacy in patients with moderate-to-severe type 2 asthma regardless of inhaled corticosteroids dose.Ian D Pavord, Arnaud Bourdin, Alberto Papi
Pageof 2
Frequent Collaborators
5 joint publications
Amr Radwan
5 joint publications
Asif Hameed Khan
4 joint publications
Nami Pandit-Abid
4 joint publications
Jérôme Msihid
4 joint publications
Scott Nash
3 joint publications
Claire Hopkins
3 joint publications
Changming Xia
3 joint publications
William Walter Busse
3 joint publications
Siddhesh Kamat
2 joint publications
Enrico Heffler
